182 related articles for article (PubMed ID: 25444840)
21. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
22. Early healing of hydroxyapatite-coated implants in grafted bone of zoledronic acid-treated osteoporotic rabbits.
Li JP; Li P; Hu J; Dong W; Liao NN; Qi MC; Li JY
J Periodontol; 2014 Feb; 85(2):308-16. PubMed ID: 23688100
[TBL] [Abstract][Full Text] [Related]
23. Sequential treatment with monofluorophosphate and zoledronic acid in osteoporotic rats.
Brance ML; Brun LR; Di Loreto VE; Lupo M; Rigalli A
Climacteric; 2014 Aug; 17(4):478-85. PubMed ID: 24205901
[TBL] [Abstract][Full Text] [Related]
24. Cancellous bone healing around strontium-doped hydroxyapatite in osteoporotic rats previously treated with zoledronic acid.
Li Y; Shui X; Zhang L; Hu J
J Biomed Mater Res B Appl Biomater; 2016 Apr; 104(3):476-81. PubMed ID: 25891947
[TBL] [Abstract][Full Text] [Related]
25. Effect of zoledronic acid on spinal fusion outcomes in an ovariectomized rat model of osteoporosis.
Yasen M; Li X; Jiang L; Yuan W; Che W; Dong J
J Orthop Res; 2015 Sep; 33(9):1297-304. PubMed ID: 26011820
[TBL] [Abstract][Full Text] [Related]
26. Bone degeneration and recovery after early and late bisphosphonate treatment of ovariectomized wistar rats assessed by in vivo micro-computed tomography.
Brouwers JE; Lambers FM; Gasser JA; van Rietbergen B; Huiskes R
Calcif Tissue Int; 2008 Mar; 82(3):202-11. PubMed ID: 18286219
[TBL] [Abstract][Full Text] [Related]
27. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
28. Does exercise modify the effects of zoledronic acid on bone mass, microarchitecture, biomechanics, and turnover in ovariectomized rats?
Lespessailles E; Jaffré C; Beaupied H; Nanyan P; Dolléans E; Benhamou CL; Courteix D
Calcif Tissue Int; 2009 Aug; 85(2):146-57. PubMed ID: 19609736
[TBL] [Abstract][Full Text] [Related]
29. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
[TBL] [Abstract][Full Text] [Related]
30. Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.
Anastasilakis AD; Polyzos SA; Efstathiadou ZA; Savvidis M; Sakellariou GT; Papatheodorou A; Kokkoris P; Makras P
Metabolism; 2015 Oct; 64(10):1291-7. PubMed ID: 26198440
[TBL] [Abstract][Full Text] [Related]
31. The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats.
Kurth AH; Eberhardt C; Müller S; Steinacker M; Schwarz M; Bauss F
Bone; 2005 Aug; 37(2):204-10. PubMed ID: 15936997
[TBL] [Abstract][Full Text] [Related]
32. Detecting early bone changes using in vivo micro-CT in ovariectomized, zoledronic acid-treated, and sham-operated rats.
Perilli E; Le V; Ma B; Salmon P; Reynolds K; Fazzalari NL
Osteoporos Int; 2010 Aug; 21(8):1371-82. PubMed ID: 19809776
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol for preventing medication-related osteonecrosis of the jaws in rats.
Vitale M; Corrêa MG; Ervolino E; Cirano FR; Ribeiro FV; Monteiro MF; Casati MZ; Pimentel SP
Oral Dis; 2024 Apr; 30(3):1462-1474. PubMed ID: 36807967
[TBL] [Abstract][Full Text] [Related]
34. Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats.
Gao Y; Luo E; Hu J; Xue J; Zhu S; Li J
Bone; 2009 Feb; 44(2):225-32. PubMed ID: 19056525
[TBL] [Abstract][Full Text] [Related]
35. Restoring implant fixation strength in osteoporotic bone with a hydrogel locally delivering zoledronic acid and bone morphogenetic protein 2. A longitudinal in vivo microCT study in rats.
Siverino C; Tirkkonen-Rajasalo L; Freitag L; Günther C; Thompson K; Styger U; Zeiter S; Eglin D; Stadelmann VA
Bone; 2024 Mar; 180():117011. PubMed ID: 38176642
[TBL] [Abstract][Full Text] [Related]
36. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
Woodis CB
Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
[TBL] [Abstract][Full Text] [Related]
37. Radiodensitometric study for evaluation of bone mineral density around dental implants after zoledronic acid treatment in ovariectomized rats.
Dikicier S; Dikicier E; Karacayli U; Erguder B
Med Oral Patol Oral Cir Bucal; 2017 May; 22(3):e377-e382. PubMed ID: 28390131
[TBL] [Abstract][Full Text] [Related]
38. The effect of bone morphometric changes on orthodontic tooth movement in an osteoporotic animal model.
Hashimoto M; Hotokezaka H; Sirisoontorn I; Nakano T; Arita K; Tanaka M; Yoshida N
Angle Orthod; 2013 Sep; 83(5):766-73. PubMed ID: 23445276
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats.
Bhandari KH; Newa M; Chapman J; Doschak MR
J Control Release; 2012 Feb; 158(1):44-52. PubMed ID: 22001608
[TBL] [Abstract][Full Text] [Related]
40. Attenuation of Antiresorptive Action in Withdrawal of Minodronic Acid for Three Months After Treatment for Twelve Months in Ovariectomized Rats.
Tanaka M; Mori H; Kawabata K
Calcif Tissue Int; 2015 Oct; 97(4):402-11. PubMed ID: 26048283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
